Home Cart Sign in  
Chemical Structure| 920519-33-1 Chemical Structure| 920519-33-1
Chemical Structure| 920519-33-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Fmoc-Asn(Trt)-Ser(psi(Me,Me)pro)-OH is used for solid phase synthesis of peptides.

Synonyms: Fmoc-Asn(Trt)-Ser(psi(Me,Me)pro)-OH

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Fmoc-Asn(Trt)-Ser(psi(Me,Me)pro)-OH

CAS No. :920519-33-1
Formula : C44H41N3O7
M.W : 723.81
SMILES Code : O=C([C@H]1N(C([C@H](CC(NC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)=O)NC(OCC5C6=C(C7=C5C=CC=C7)C=CC=C6)=O)=O)C(C)(C)OC1)O
Synonyms :
Fmoc-Asn(Trt)-Ser(psi(Me,Me)pro)-OH
MDL No. :MFCD10001368

Safety of Fmoc-Asn(Trt)-Ser(psi(Me,Me)pro)-OH

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Application In Synthesis of Fmoc-Asn(Trt)-Ser(psi(Me,Me)pro)-OH

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 920519-33-1 ]

[ 920519-33-1 ] Synthesis Path-Downstream   1~5

  • 1
  • C23H27N2O4Pol [ No CAS ]
  • [ 29022-11-5 ]
  • [ 920519-33-1 ]
  • [ 71989-31-6 ]
  • [ 71989-23-6 ]
  • [ 71989-26-9 ]
  • [ 103213-32-7 ]
  • [ 132388-59-1 ]
  • [ 132327-80-1 ]
  • [ 67436-13-9 ]
  • [ 86060-81-3 ]
  • [ 102410-65-1 ]
  • mouse linear [A10,A22]-hepcidin-1 (C7: SH, C23: SH; C11: S-Acm, C19: S-Acm; C13: S-tBu, C14: S-tBu) [ No CAS ]
  • 2
  • C23H27N2O4Pol [ No CAS ]
  • [ 29022-11-5 ]
  • [ 920519-33-1 ]
  • [ 71989-31-6 ]
  • [ 71989-23-6 ]
  • [ 71989-26-9 ]
  • [ 103213-32-7 ]
  • [ 132388-59-1 ]
  • [ 132327-80-1 ]
  • [ 67436-13-9 ]
  • [ 86060-81-3 ]
  • [ 102410-65-1 ]
  • mouse linear [A11,A19]-hepcidin-2 (C7: SH, C23: SH; C10: S-Acm, C13: S-Acm; C14: S-tBu C22: S-tBu) [ No CAS ]
  • 3
  • [ 29022-11-5 ]
  • [ 68858-20-8 ]
  • [ 35661-60-0 ]
  • [ 920519-33-1 ]
  • FmocHN-Gln(tBu)-Thr(ΨMe,MePro)-COOH [ No CAS ]
  • BocHN-Ser(<SUP>t</SUP>Bu)-His(Trt)-Lys(Boc)-Gly-COOH [ No CAS ]
  • [ 71989-31-6 ]
  • [ 35661-40-6 ]
  • [ 71989-14-5 ]
  • [ 71989-18-9 ]
  • [ 71989-38-3 ]
  • [ 71989-26-9 ]
  • [ 71989-28-1 ]
  • [ 73724-43-3 ]
  • [ 109425-51-6 ]
  • [ 131287-39-3 ]
  • Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine [ No CAS ]
  • Boc-NH-S(tBu)H(Trt)MD(OtBu)PR(Pbf)GN(Trt)S(ΨPro)E(OtBu)LLY(tBu)H(Trt)N(N-(2-(N-acetyl)amino-2-deoxy-3,4,6-tri-O-acetyl-β-D-glucopyranosyl))QT(ΨPro)(tBu)VFY(tBu)R(Pbf)R(Pbf)PC(StBu)H(Trt)GE(OtBu)K(Boc)-COOH [ No CAS ]
  • 4
  • Fmoc-β-Ala-Wang resin [ No CAS ]
  • [ 957780-52-8 ]
  • [ 29022-11-5 ]
  • [ 35661-60-0 ]
  • [ 35661-39-3 ]
  • [ 920519-33-1 ]
  • [ 35661-40-6 ]
  • [ 71989-18-9 ]
  • [ 71989-23-6 ]
  • [ 71989-38-3 ]
  • [ 71989-26-9 ]
  • [ 132327-80-1 ]
  • N-2,N-6-bis(9-fluorenylmethyloxycarbonyl)-L-lysine [ No CAS ]
  • [QYIKANSKFIGITEL]4-K2-K-β-Ala-resin [ No CAS ]
  • 5
  • N-alpha-Fmoc-N-beta-O-t-butyl-L-aspartyl-N-α-(2,4-dimethoxybenzyl)glycine [ No CAS ]
  • [ 29022-11-5 ]
  • [ 68858-20-8 ]
  • [ 35661-60-0 ]
  • [ 13734-34-4 ]
  • [ 957780-56-2 ]
  • [ 35661-39-3 ]
  • [ 920519-33-1 ]
  • (2S)-N-((9H-fluoren-9-ylmethyloxy)carbonyl)aspartic acid-4-((3-ethyl)pent-3-yl) ester [ No CAS ]
  • Fmoc-Gly-Ser(ψMe,MePro)-OH [ No CAS ]
  • Fmoc-Gln(Trt)-Thr(ψMe,MePro)-OH [ No CAS ]
  • [ 71989-31-6 ]
  • [ 35661-40-6 ]
  • [ 71989-33-8 ]
  • [ 71989-14-5 ]
  • [ 71989-18-9 ]
  • [ 71989-23-6 ]
  • [ 71989-38-3 ]
  • [ 71989-26-9 ]
  • [ 103213-32-7 ]
  • [ 71989-35-0 ]
  • [ 132388-59-1 ]
  • [ 132327-80-1 ]
  • [ 86060-81-3 ]
  • [ 109425-51-6 ]
  • [ 77284-32-3 ]
  • Nα-(9-fluorenylmethyloxycarbonyl)-Nγ-2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl-L-arginine [ No CAS ]
  • [Cys105,Nle125,170,Cys(Acm)165,182,189,Asn107,Asp109](105-191)hGH-NH2 [ No CAS ]
YieldReaction ConditionsOperation in experiment
101.1 mg General procedure: The syntheses of the fragments were performed on an automatic peptide synthesizer under microwave conditions using an 8-fold excess of 0.5 M amino acids, 0.5 M HATU/NMP, 2 M DIEA /NMP or 1.0 M DIC/NMP and 0.5 M Oxyma /NMP. The final concentration of Fmoc-amino acids was 0.2 M. The coupling cycles were conducted according to Table 1. Fmoc deprotection was carried out using 35% piperidine/NMP containing 0.1 M HOBt at room temperature for 2 and 6 min, followed by 4 min at 48 C.
 

Historical Records

Categories